Lexaria Bioscience raises $5.9M through warrant exercise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. META
3. SPY
4. ANT
5. CART
6. FFAI
7. TSLA
8. FFR
9. XNCR
10. AZN

Go back to Lexaria Bioscience raises $5.9M through warrant exercise

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

September 8, 2026 8:01 AM EDT

KELOWNA, BC / ACCESS Newswire / September 8, 2026 / Lexaria Bioscience Corp. (NASDAQ: LEXX)(NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 453,969 shares of the Company's common stock originally issued by the Company on February 16, 2024, having an original exercise price of $32.78 per share, on October 16, 2024, having an original exercise price of $45.90 per share, on September 29, 2025,... More